Rene Opavsky, PhD
Professor
On This Page
Teaching Profile
Courses Taught
-
GMS6647 – Transcriptional and Translational Control of Cell Growth and Proliferation
College of Medicine
-
GMS6691 – Special Topics in Cell Biology and Anatomy
College of Medicine
-
GMS6421 – Cell Biology
College of Medicine
-
GMS6061 – Nuclear Structure and Dynamics
College of Medicine
-
GMS6064 – Tumor Biology
College of Medicine
-
GMS6001 – Fundamentals of Biomedical Sciences I
College of Medicine
-
GMS6335 – Advanced Stem Cell Biology: Tissue Engineering
College of Medicine
Research Profile
Cytosine methylation is a heritable epigenetic modification affecting gene transcription and the integrity of the genome. In human malignancies, aberrant DNA methylation is the most commonly observed epimutation, often manifested by promoter hypermethylation of tumor suppressor genes and hypomethylation of intergenic non-coding regions. The DNA methyltransferases (DNMTs) DNMT1, DNMT3A, and DNMT3B are the enzymes primarily responsible for methylation of CpG dinucleotides in mammalian DNA. Mutations in the coding sequence of DNMT3A are frequently found in human hematologic malignancies indicating that decreased DNMT3A activity may promote tumorigenesis in multiple hematopoietic lineages. Using targeted inactivation of Dnmt3a in mice Opavsky lab showed that Dnmt3a plays a tumor suppressor role in prevention of chronic B-cell lymphocytic leukemia, peripheral T cell lymphoma and myeloproliferative disease. Furthermore, Dnmt3b is a tumor suppressor gene in prevention of MYC-induced T cell lymphomas. Promoter hypomethylation accompanied by increased gene expression was found to be a frequent event in both mouse and human hematologic malignancies.
RESEARCH PROJECTS
Current projects in Opavsky lab focus on evaluation of functions performed by DNMTs in normal and malignant hematopoiesis utilizing mouse models, genome-wide approaches and in vivo functional studies of DNMT target genes. We are in particular interested in a role of promoter hypomethylation in cellular transformation in order to identify oncogenes for therapeutic targeting.
Publications
Academic Articles
Grants
-
The Florida Summer Training in Research and Oncology for the Next Generation of Researchers (STRONGER) Program
Active
- Role:
- Faculty
- Funding:
- NATL INST OF HLTH NCI
-
Dnmt3b activities in mouse development
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NIGMS
-
The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NCI
-
UF Health Cancer Center Pilot Project Grants funded through the Florida Consortium of National Cancer Institute Centers Program
- Role:
- Project Manager
- Funding:
- UF HEALTH SHANDS HOSPITAL
Education
-
PhD, Molecular Biology
Department of Molecular Biology, Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovak Republic
-
MSc, Biochemistry
Comenius University, Bratislava, Slovak Republic
Contact Details
- Business:
- (352) 294-8596
- Business:
- ropavsky@ufl.edu
- Business Mailing:
-
PO Box 103633
GAINESVILLE FL 32610 - Business Street:
-
CGRC 258
2033 MOWRY RD
Gainesville FL 32610